Defining anti-synthetase syndrome: a systematic literature review
- PMID: 35225224
- PMCID: PMC10411341
- DOI: 10.55563/clinexprheumatol/8xj0b9
Defining anti-synthetase syndrome: a systematic literature review
Abstract
Objectives: Anti-synthetase syndrome (ASSD) is a heterogeneous autoimmune disease characterised by multi-system involvement with a wide variety of manifestations. Validated classification criteria are necessary to improve recognition and prevent misclassification, especially given the lack of reliable and standardised autoantibody testing. We systematically reviewed the literature to analyse proposed ASSD criteria, characteristics, and diagnostic performance.
Methods: We searched PubMed and Embase databases (01/01/1984 to 06/11/2018) and the ACR and EULAR meeting abstracts (2017-2018). Sensitivities, specificities, positive, negative likelihood ratios and risk of bias were calculated for ASSD criteria and key variables reported in the literature. We performed meta-analysis when appropriate.
Results: We retrieved 4,358 studies. We found 85 proposed ASSD criteria from a total of 82 studies. All but one study included anti-synthetase autoantibody (ARS) positivity in the ASSD criteria. Most studies required only one ASSD feature plus anti-ARS to define ASSD (n=64, 78%), whereas 16 studies required more than one ASSD variable plus anti-ARS. The only criteria not including anti-ARS positivity required 5 ASSD clinical features. We found limited data and wide variability in the diagnostic performance of each variable and definition proposed in the literature. Given these limitations we only meta-analysed the performance of individual muscle biopsy and clinical variables in diagnosing ASSD, which performed poorly.
Conclusions: The current ASSD criteria include a variety of serological, clinical, and histological features with wide variability amongst proposed definitions and the performance of these definitions has not been tested. This systematic literature review suggests the need for additional data and consensus-driven classification criteria for ASSD.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10411341/bin/nihms-1919681-f0001.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10411341/bin/nihms-1919681-f0002.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10411341/bin/nihms-1919681-f0003.gif)
![Figure 4:](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10411341/bin/nihms-1919681-f0004.gif)
Similar articles
-
Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.J Autoimmun. 2023 Jan;134:102951. doi: 10.1016/j.jaut.2022.102951. Epub 2022 Dec 2. J Autoimmun. 2023. PMID: 36470210
-
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.Clin Exp Rheumatol. 2024 Feb;42(2):277-287. doi: 10.55563/clinexprheumatol/s14zq8. Epub 2024 Mar 14. Clin Exp Rheumatol. 2024. PMID: 38488094
-
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Autoimmun Rev. 2017. PMID: 28147261 Review.
-
Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.BMC Pulm Med. 2021 Feb 12;21(1):57. doi: 10.1186/s12890-021-01399-5. BMC Pulm Med. 2021. PMID: 33579248 Free PMC article.
-
Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.Front Immunol. 2022 May 13;13:866087. doi: 10.3389/fimmu.2022.866087. eCollection 2022. Front Immunol. 2022. PMID: 35634293 Free PMC article. Review.
Cited by
-
Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis.Rheumatol Adv Pract. 2024 Apr 8;8(2):rkae049. doi: 10.1093/rap/rkae049. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38708024 Free PMC article.
-
A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.Int J Mol Sci. 2024 Apr 18;25(8):4453. doi: 10.3390/ijms25084453. Int J Mol Sci. 2024. PMID: 38674039 Free PMC article. Review.
-
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.Nat Rev Rheumatol. 2024 May;20(5):313-314. doi: 10.1038/s41584-024-01106-8. Nat Rev Rheumatol. 2024. PMID: 38514812 No abstract available.
-
Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.Nat Rev Rheumatol. 2024 May;20(5):311-312. doi: 10.1038/s41584-024-01105-9. Nat Rev Rheumatol. 2024. PMID: 38514811 No abstract available.
-
Clinical evolution of antisynthetase syndrome-associated interstitial lung disease after COVID-19 in a man with Klinefelter syndrome: A case report.World J Clin Cases. 2024 Feb 26;12(6):1144-1149. doi: 10.12998/wjcc.v12.i6.1144. World J Clin Cases. 2024. PMID: 38464923 Free PMC article.
References
-
- Mirrakhimov AE. Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. Curr Med Chem 2015;22:1963–75. - PubMed
-
- Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138:1464–74. - PubMed
-
- Lega J-C, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 2014;13:883–91. - PubMed
-
- Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019–38. - PubMed
-
- Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971–82. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical